遺伝子検査の世界市場レポート 2025

遺伝子検査市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.8％で304億5,000万米ドルに成長します。予測期間の成長は、政府支援の増加、遺伝性疾患の有病率の上昇、老年人口の増加、慢性疾患の有病率の上昇に起因しています。予測期間の主な動向としては、遺伝カウンセリングや次世代遺伝子検査の開発を支援する情報学プログラムなどの新しいプログラムの導入、技術の進歩、消費者直接遺伝子検査の開始などが挙げられます。

遺伝性疾患の有病率の増加は、今後の遺伝子検査市場の成長を促進すると予想されます。遺伝性疾患は、出生時に発現することもあれば、時間の経過とともに発症することもあり、遺伝子検査はこれらの問題を診断し、がんなどの疾患の発症の可能性に関する洞察を提供するのに役立っています。例えば、2024年、スイスに本部を置く政府間機関である世界保健機関（WHO）の報告書によると、遺伝性疾患や先天性異常は、出生児の2％から5％に影響を及ぼし、小児科入院の30％を占め、先進国における小児死亡の約50％に寄与しています。このように、遺伝性疾患の有病率の上昇が遺伝子検査市場の成長を促進しています。

慢性疾患の増加は、遺伝子検査市場の成長をさらに促進すると予想されます。慢性疾患は、多くの場合、その人の一生を左右するほど長期にわたることが特徴であり、疾患の予防、管理、治療には十分な情報に基づいた判断が必要です。遺伝子検査は、特に慢性疾患において、個人とヘルスケアプロバイダーが十分な情報を得た上で意思決定できるようにする上で重要な役割を果たしています。2023年9月の世界保健機関（WHO）の発表によると、慢性疾患は年間死亡者数4,100万人のうち74％を占め、心血管疾患、がん、慢性呼吸器疾患、糖尿病が主な原因となっています。したがって、慢性疾患の有病率の増加が遺伝子検査市場の主要な促進要因となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界遺伝子検査PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の遺伝子検査市場：成長率分析
• 世界の遺伝子検査市場の実績：規模と成長, 2019-2024
• 世界の遺伝子検査市場の予測：規模と成長, 2024-2029, 2034F
• 世界遺伝子検査総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の遺伝子検査市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 予測テスト
• キャリアテスト
• 出生前検査および新生児検査
• 診断検査
• 薬理ゲノム検査
• 栄養ゲノム検査
• その他のタイプ
• 世界の遺伝子検査市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 細胞遺伝学的検査
• 生化学検査
• 分子検査
• 世界の遺伝子検査市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• がんの診断
• 遺伝性疾患の診断
• 心血管疾患の診断
• その他の用途
• 世界の遺伝子検査市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と診療所
• 診断研究所およびセンター
• その他のエンドユーザー
• 世界の遺伝子検査市場、予測テストのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 遺伝的リスク評価
• 家族歴に基づく検査
• 世界の遺伝子検査市場、キャリアテストのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 単一遺伝子キャリア検査
• キャリアスクリーニングの拡大
• 世界の遺伝子検査市場出生前検査と新生児検査の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 非侵襲的出生前検査（NIPT）
• 新生児スクリーニング検査
• 世界の遺伝子検査市場、診断検査のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 確認遺伝子検査
• 臨床診断検査
• 世界の遺伝子検査市場、薬理ゲノム検査のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 薬物反応テスト
• 薬物有害反応検査
• 世界の遺伝子検査市場、栄養ゲノム検査の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 食事反応テスト
• 代謝検査
• 世界の遺伝子検査市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 祖先検査
• 全ゲノム配列解析

第7章 地域別・国別分析

• 世界の遺伝子検査市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の遺伝子検査市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 遺伝子検査市場：競合情勢
• 遺伝子検査市場：企業プロファイル
  • Myriad Genetics Inc Overview, Products and Services, Strategy and Financial Analysis
  • Illumina Inc Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Eurofins Scientific Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• F. Hoffmann-La Roche Ltd
• Quest Diagnostics Incorporated
• Qiagen NV
• Thermo Fisher Scientific Inc.
• BioRad Laboratories Inc.
• BGI
• Berry Genomics Co. ltd
• Daan Gene Co. Ltd
• Annoroad Gene Technology Co. Ltd
• WuXi PharmaTech
• Igenomix
• Circle DNA
• Centogene
• Curetis
• Cytena

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 遺伝子検査市場2029：新たな機会を提供する国
• 遺伝子検査市場2029：新たな機会を提供するセグメント
• 遺伝子検査市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Genetic testing is a type of medical examination that seeks alterations in genes, proteins, or chromosomes. The results of a genetic test can identify a genetic ailment and determine a person's risk of developing a genetic disorder. This testing is utilized to confirm specific genetic disorders in children based on physical signs and symptoms.

The main types of genetic testing include predictive testing, carrier testing, prenatal and newborn testing, diagnostic testing, pharmacogenomic testing, nutrigenomic testing, and other types. Predictive tests belong to a new and rapidly expanding class of medical tests that differ fundamentally from traditional diagnostic examinations. Various technologies are involved in genetic testing, such as cytogenetic testing, biochemical testing, and molecular testing. It is applied in several areas, including cancer diagnosis, genetic disease diagnosis, cardiovascular disease diagnosis, and others, with end users including hospitals and clinics, diagnostic laboratories and centers, and others.

The genetic testing market research report is one of a series of new reports from The Business Research Company that provides genetic testing market statistics, including global market size, regional shares, competitors with a genetic testing market share, detailed genetic testing market segments, market trends and opportunities, and any further data you may need to thrive in the genetic testing industry. This genetic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The genetic testing market size has grown strongly in recent years. It will grow from $19.1 billion in 2024 to $20.92 billion in 2025 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to increasing healthcare expenditure, a rise in cancer prevalence, an increase in demand for personalized medicine, and the emergence of novel infectious diseases.

The genetic testing market size is expected to see strong growth in the next few years. It will grow to $30.45 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to increasing government support, rising prevalence of genetic disorders, rising geriatric population, and increase in chronic disease prevalence. Major trends in the forecast period include introducing new programs such as genetic counseling and informatics programs that will assist in developing the next generation of genetic testing, technological advancement, and launching direct-to-consumer genetic tests.

The increasing prevalence of genetic disorders is expected to drive the growth of the genetic testing market in the future. Genetic disorders can manifest at birth or develop over time, and genetic testing is instrumental in diagnosing these issues and providing insights into the likelihood of developing conditions such as cancer. For example, in 2024, a report from the World Health Organization, a Switzerland-based intergovernmental organization, indicated that genetic disorders and congenital abnormalities affect 2% to 5% of live births and account for 30% of pediatric hospital admissions, contributing to about 50% of childhood deaths in industrialized countries. Thus, the rising prevalence of genetic disorders is fueling the growth of the genetic testing market.

The escalating number of chronic diseases is expected to further drive the growth of the genetic testing market. Chronic diseases, characterized by prolonged durations often lasting a person's lifetime, necessitate informed decisions for disease prevention, management, and treatment. Genetic testing plays a crucial role in empowering individuals and healthcare providers to make such informed decisions, particularly in the context of chronic diseases. Globally, chronic diseases account for 74% of 41 million annual deaths, with cardiovascular diseases, cancer, chronic respiratory diseases, and diabetes being major contributors, according to the World Health Organization in September 2023. Hence, the increasing prevalence of chronic diseases is a key driver of the genetic testing market.

Direct-to-consumer genetic tests represent a significant trend gaining momentum in the genetic testing market. Known as at-home DNA tests, these direct-to-consumer deoxyribonucleic acid (DNA) tests allow individuals to collect samples at home and send them off for analysis to evaluate their genetic risk for specific diseases. Home-based genetic testing analyzes individuals' DNA to identify gene variations that may increase the likelihood of developing certain medical conditions. For instance, in 2022, DNALabs, an India-based company focused on genetic testing solutions to advance personalized medicine, launched At-Home Genetic Testing Solutions. This service empowers individuals to make informed decisions with just a simple cheek swab using an at-home DNA collection kit, catering to both consumers taking charge of their health and healthcare professionals aiming to tailor optimal treatments for their patients.

The introduction of new programs is a significant trend gaining traction in the genetic testing market. Companies in this sector are emphasizing the expansion of diversity in healthcare through innovative genetic counseling and informatics initiatives that will aid in developing the next generation of genetic testing. For example, in June 2022, Illumina, Inc., a US-based company renowned for its cutting-edge technologies in genetic variation analysis, launched a research test co-developed with Merck aimed at providing deeper insights into the tumor genome. This initiative builds on Illumina's dedication to enabling comprehensive genomic profiling and bolstering research essential for precision medicine in oncology. The widely utilized TruSight Oncology 500 assay has now incorporated the evaluation of a novel genetic signature. This offering will be available globally, excluding the United States and Japan, and will assist researchers in gaining a more profound understanding of the tumor genome by identifying genetic alterations linked to homologous recombination deficiency (HRD).

In January 2022, Exact Sciences, a US-based molecular diagnostics company specializing in genetic testing products, acquired Prevention Genetics in a deal valued at $190 million. Through this acquisition, Exact Sciences intends to expand hereditary cancer testing access to more patients. Prevention Genetics, a US-based company, produces clinical DNA (genetic) tests for inherited genetic conditions.

Major companies operating in the genetic testing market include Myriad Genetics Inc, Illumina Inc, Abbott Laboratories, Eurofins Scientific, Danaher Corporation, F. Hoffmann-La Roche Ltd, Quest Diagnostics Incorporated, Qiagen NV, Thermo Fisher Scientific Inc., BioRad Laboratories Inc., BGI, Berry Genomics Co. ltd, Daan Gene Co. Ltd, Annoroad Gene Technology Co. Ltd, WuXi PharmaTech, Igenomix, Circle DNA, Centogene, Curetis, Cytena, Probably Genetic, Genome Biologics, WuXi NextCODE, Genomtec, Testgene, Evogen Lab, Phosphorus, Helix, Sequencing, 10x Genomics, Quantgene, Virica Biotech, DNALabs, Deep Genomics, SGS Mexico, Hologic Inc, 23andMe Inc, Middle East Testing Services L.L.C, Molecular Biology & Genetics Laboratory, Freiburg Medical Laboratory Middle East, IVI MIDDLE EAST FERTILITY CLINIC, Bio Certica

North America was the largest region in the genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the genetic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The genetic testing market includes revenues earned by entities by chromosomal genetic tests, molecular genetic tests (or gene tests), biochemical tests, newborn screening, and diagnostic testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Genetic Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on genetic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for genetic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The genetic testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Predictive Testing, Carrier Testing, Prenatal And Newborn Testing, Diagnostic Testing, Pharmacogenomics Testing, Nutrigenomic Testing, Other Types
• 2) By Technology: Cytogenetic Testing, Biochemical Testing, Molecular Testing
• 3) By Application: Cancer Diagnosis, Genetic Disease Diagnosis, Cardiovascular Disease Diagnosis, Other Applications
• 4) By End User: Hospitals And Clinics, Diagnostic Laboratories And Centres, Other End Users
• Subsegments:
• 1) By Predictive Testing: Genetic Risk Assessment; Family History-Based Testing
• 2) By Carrier Testing: Single Gene Carrier Testing; Expanded Carrier Screening
• 3) By Prenatal And Newborn Testing: Non-Invasive Prenatal Testing (NIPT); Newborn Screening Tests
• 4) By Diagnostic Testing: Confirmatory Genetic Testing; Clinical Diagnostic Testing
• 5) By Pharmacogenomics Testing: Drug Response Testing; Adverse Drug Reaction Testing
• 6) By Nutrigenomic Testing: Dietary Response Testing; Metabolism Testing
• 7) By Other Types: Ancestry Testing; Whole Genome Sequencing
• Companies Mentioned: Myriad Genetics Inc; Illumina Inc; Abbott Laboratories; Eurofins Scientific; Danaher Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Genetic Testing Market Characteristics

3. Genetic Testing Market Trends And Strategies

4. Genetic Testing Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Genetic Testing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Genetic Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Genetic Testing Market Growth Rate Analysis
• 5.4. Global Genetic Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Genetic Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Genetic Testing Total Addressable Market (TAM)

6. Genetic Testing Market Segmentation

• 6.1. Global Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Predictive Testing
• Carrier Testing
• Prenatal and Newborn Testing
• Diagnostic Testing
• Pharmacogenomic Testing
• Nutrigenomic Testing
• Other Types
• 6.2. Global Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cytogenetic Testing
• Biochemical Testing
• Molecular Testing
• 6.3. Global Genetic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cancer Diagnosis
• Genetic Disease Diagnosis
• Cardiovascular Disease Diagnosis
• Other Applications
• 6.4. Global Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Diagnostic Laboratories And Centres
• Other End Users
• 6.5. Global Genetic Testing Market, Sub-Segmentation Of Predictive Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Genetic Risk Assessment
• Family History-Based Testing
• 6.6. Global Genetic Testing Market, Sub-Segmentation Of Carrier Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single Gene Carrier Testing
• Expanded Carrier Screening
• 6.7. Global Genetic Testing Market, Sub-Segmentation Of Prenatal And Newborn Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Non-Invasive Prenatal Testing (NIPT)
• Newborn Screening Tests
• 6.8. Global Genetic Testing Market, Sub-Segmentation Of Diagnostic Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Confirmatory Genetic Testing
• Clinical Diagnostic Testing
• 6.9. Global Genetic Testing Market, Sub-Segmentation Of Pharmacogenomics Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Response Testing
• Adverse Drug Reaction Testing
• 6.10. Global Genetic Testing Market, Sub-Segmentation Of Nutrigenomic Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dietary Response Testing
• Metabolism Testing
• 6.11. Global Genetic Testing Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ancestry Testing
• Whole Genome Sequencing

7. Genetic Testing Market Regional And Country Analysis

• 7.1. Global Genetic Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Genetic Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Genetic Testing Market

• 8.1. Asia-Pacific Genetic Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Genetic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Genetic Testing Market

• 9.1. China Genetic Testing Market Overview
• 9.2. China Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Genetic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Genetic Testing Market

• 10.1. India Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Genetic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Genetic Testing Market

• 11.1. Japan Genetic Testing Market Overview
• 11.2. Japan Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Genetic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Genetic Testing Market

• 12.1. Australia Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Genetic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Genetic Testing Market

• 13.1. Indonesia Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Genetic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Genetic Testing Market

• 14.1. South Korea Genetic Testing Market Overview
• 14.2. South Korea Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Genetic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Genetic Testing Market

• 15.1. Western Europe Genetic Testing Market Overview
• 15.2. Western Europe Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Genetic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Genetic Testing Market

• 16.1. UK Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Genetic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Genetic Testing Market

• 17.1. Germany Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Genetic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Genetic Testing Market

• 18.1. France Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Genetic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Genetic Testing Market

• 19.1. Italy Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Genetic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Genetic Testing Market

• 20.1. Spain Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Genetic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Genetic Testing Market

• 21.1. Eastern Europe Genetic Testing Market Overview
• 21.2. Eastern Europe Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Genetic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Genetic Testing Market

• 22.1. Russia Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Genetic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Genetic Testing Market

• 23.1. North America Genetic Testing Market Overview
• 23.2. North America Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Genetic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Genetic Testing Market

• 24.1. USA Genetic Testing Market Overview
• 24.2. USA Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Genetic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Genetic Testing Market

• 25.1. Canada Genetic Testing Market Overview
• 25.2. Canada Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Genetic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Genetic Testing Market

• 26.1. South America Genetic Testing Market Overview
• 26.2. South America Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Genetic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Genetic Testing Market

• 27.1. Brazil Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Genetic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Genetic Testing Market

• 28.1. Middle East Genetic Testing Market Overview
• 28.2. Middle East Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Genetic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Genetic Testing Market

• 29.1. Africa Genetic Testing Market Overview
• 29.2. Africa Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Genetic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Genetic Testing Market Competitive Landscape And Company Profiles

• 30.1. Genetic Testing Market Competitive Landscape
• 30.2. Genetic Testing Market Company Profiles
  • 30.2.1. Myriad Genetics Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Illumina Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Eurofins Scientific Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Genetic Testing Market Other Major And Innovative Companies

• 31.1. F. Hoffmann-La Roche Ltd
• 31.2. Quest Diagnostics Incorporated
• 31.3. Qiagen NV
• 31.4. Thermo Fisher Scientific Inc.
• 31.5. BioRad Laboratories Inc.
• 31.6. BGI
• 31.7. Berry Genomics Co. ltd
• 31.8. Daan Gene Co. Ltd
• 31.9. Annoroad Gene Technology Co. Ltd
• 31.10. WuXi PharmaTech
• 31.11. Igenomix
• 31.12. Circle DNA
• 31.13. Centogene
• 31.14. Curetis
• 31.15. Cytena

32. Global Genetic Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Genetic Testing Market

34. Recent Developments In The Genetic Testing Market

35. Genetic Testing Market High Potential Countries, Segments and Strategies

• 35.1 Genetic Testing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Genetic Testing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Genetic Testing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer